These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 16982335)

  • 21. Action of protein kinase A regulators on secretory activity of porcine granulosa cells in vitro.
    Makarevich AV; Sirotkin AV; Genieser HG
    Anim Reprod Sci; 2004 Mar; 81(1-2):125-36. PubMed ID: 14749054
    [TBL] [Abstract][Full Text] [Related]  

  • 22. LY294002-mediated inhibition of phosphatidylinositol 3-kinase activity triggers growth inhibition and apoptosis in CD40-triggered Ramos-Burkitt lymphoma B cells.
    Curnock AP; Knox KA
    Cell Immunol; 1998 Aug; 187(2):77-87. PubMed ID: 9732695
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The expansion of megakaryocyte progenitors from CD34+-enriched mobilized peripheral blood stem cells is inhibited by Flt3-L.
    Case J; Hicks C; Trickett A; Kwan YL; Manoharan A
    J Interferon Cytokine Res; 2006 Feb; 26(2):76-82. PubMed ID: 16487027
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glucagon-like peptide-1 inhibits apoptosis of insulin-secreting cells via a cyclic 5'-adenosine monophosphate-dependent protein kinase A- and a phosphatidylinositol 3-kinase-dependent pathway.
    Hui H; Nourparvar A; Zhao X; Perfetti R
    Endocrinology; 2003 Apr; 144(4):1444-55. PubMed ID: 12639928
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Activation of cAMP signaling transiently inhibits apoptosis in vascular smooth muscle cells in a site upstream of caspase-3.
    Orlov SN; Thorin-Trescases N; Dulin NO; Dam TV; Fortuno MA; Tremblay J; Hamet P
    Cell Death Differ; 1999 Jul; 6(7):661-72. PubMed ID: 10453077
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A common downstream signaling activity of osteoclast survival factors that prevent nitric oxide-promoted osteoclast apoptosis.
    Kanaoka K; Kobayashi Y; Hashimoto F; Nakashima T; Shibata M; Kobayashi K; Kato Y; Sakai H
    Endocrinology; 2000 Aug; 141(8):2995-3005. PubMed ID: 10919288
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antiapoptotic role of endogenous nitric oxide in human melanoma cells.
    Salvucci O; Carsana M; Bersani I; Tragni G; Anichini A
    Cancer Res; 2001 Jan; 61(1):318-26. PubMed ID: 11196180
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nitric oxide suppresses apoptosis in human colon cancer cells by scavenging mitochondrial superoxide anions.
    Wenzel U; Kuntz S; De Sousa UJ; Daniel H
    Int J Cancer; 2003 Sep; 106(5):666-75. PubMed ID: 12866025
    [TBL] [Abstract][Full Text] [Related]  

  • 29. cAMP inhibits bile acid-induced apoptosis by blocking caspase activation and cytochrome c release.
    Webster CR; Usechak P; Anwer MS
    Am J Physiol Gastrointest Liver Physiol; 2002 Sep; 283(3):G727-38. PubMed ID: 12181189
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ex vivo expansion of CD34+ umbilical cord blood cells in a defined serum-free medium (QBSF-60) with early effect cytokines.
    Qiu L; Meagher R; Welhausen S; Heye M; Brown R; Herzig RH
    J Hematother Stem Cell Res; 1999 Dec; 8(6):609-18. PubMed ID: 10645768
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Actin inhibition increases megakaryocyte proplatelet formation through an apoptosis-dependent mechanism.
    Avanzi MP; Izak M; Oluwadara OE; Mitchell WB
    PLoS One; 2015; 10(4):e0125057. PubMed ID: 25875470
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Study of early hematopoietic precursors in human cord blood.
    Abboud M; Xu F; LaVia M; Laver J
    Exp Hematol; 1992 Oct; 20(9):1043-7. PubMed ID: 1281782
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The reduction of in vitro radiation-induced Fas-related apoptosis in CD34+ progenitor cells by SCF, FLT-3 ligand, TPO, and IL-3 in combination resulted in CD34+ cell proliferation and differentiation.
    Drouet M; Mathieu J; Grenier N; Multon E; Sotto JJ; Herodin F
    Stem Cells; 1999; 17(5):273-85. PubMed ID: 10527462
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of recombinant human thrombopoietin alone and in combination with erythropoietin and early-acting cytokines on human mobilized purified CD34+ progenitor cells cultured in serum-depleted medium.
    Birkmann J; Oez S; Smetak M; Kaiser G; Kappauf H; Gallmeier WM
    Stem Cells; 1997; 15(1):18-32. PubMed ID: 9007219
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ex vivo expansion of megakaryocyte progenitors: effect of various growth factor combinations on CD34+ progenitor cells from bone marrow and G-CSF-mobilized peripheral blood.
    Gehling UM; Ryder JW; Hogan CJ; Hami L; McNiece I; Franklin W; Williams S; Helm K; King J; Shpall EJ
    Exp Hematol; 1997 Oct; 25(11):1125-39. PubMed ID: 9328449
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Attenuation of macrophage apoptosis by the cAMP-signaling system.
    von Knethen A; Brüne B
    Mol Cell Biochem; 2000 Sep; 212(1-2):35-43. PubMed ID: 11108134
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Apoptosis of erythroid precursors under stimulation with thrombopoietin: contribution to megakaryocytic lineage choice.
    Sawai N; Koike K; Ito S; Kurokawa Y; Mwamtemi HH; Kinoshita T; Sakashita K; Higuchi T; Takeuchi K; Shiohara M; Ogami K; Komiyama A
    Stem Cells; 1999; 17(1):45-53. PubMed ID: 10215401
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CD226 is expressed on the megakaryocytic lineage from hematopoietic stem cells/progenitor cells and involved in its polyploidization.
    Ma D; Sun Y; Lin D; Wang H; Dai B; Zhang X; Ouyang W; Jian J; Jia W; Xu X; Jin B
    Eur J Haematol; 2005 Mar; 74(3):228-40. PubMed ID: 15693793
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Thrombopoietin enhances neutrophil production by bone marrow hematopoietic progenitors with the aid of stem cell factor in congenital neutropenia.
    Sawai N; Koike K; Mwamtemi HH; Ito S; Kurokawa Y; Sakashita K; Kinoshita T; Higuchi T; Takeuchi K; Shiohara M; Kamijo T; Higuchi Y; Miyazaki H; Kato T; Kobayashi M; Miyake M; Yasui K; Komiyama A
    J Leukoc Biol; 2000 Jul; 68(1):137-43. PubMed ID: 10914501
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The lethal effects of pharmacological cyclin-dependent kinase inhibitors in human leukemia cells proceed through a phosphatidylinositol 3-kinase/Akt-dependent process.
    Yu C; Rahmani M; Dai Y; Conrad D; Krystal G; Dent P; Grant S
    Cancer Res; 2003 Apr; 63(8):1822-33. PubMed ID: 12702569
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.